The CJEU has handled the Hungarian referral in case C-181/24 with a straightforward confirmation that an application for a SPC must be based on the first marketing authorisation for the product.
The Danish Consumer Ombudsman very recently published new recommendations relating to environmental marketing designed to help businesses avoid greenwashing.
In recent years, greenwashing in cosmetics has come under increased legal scrutiny.
The Central Division (Munich) has handed down a significant revocation decision in the ongoing patent battle between NanoString v 10x Genomics and President and Fellows of Harvard College.
The connection between IP and competition law may not be immediately obvious. However, it is important to bear in mind that competition law affects all commercial dealings, including intellectual property transactions.
AI's role in healthcare is expanding, enhancing diagnosis, treatment planning, administrative efficiency, and drug discovery. With the EU AI Act now in force, healthcare companies face an urgent need to ensure compliance.
The CJEU has handled the Hungarian referral in case C-181/24 with a straightforward confirmation that an application for a SPC must be based on the first marketing authorisation for the product.
If your next invention is going to have the commercial impact it should, you will need to correctly identify, protect, exploit, and enforce it. This is exactly what Potter Clarkson’s patent attorneys in Copenhagen do.
The Supreme Administrative Court in the Czech Republic has asked the CJEU whether a substance classified as an excipient in a marketing authorisation can still be considered an active ingredient for an SPC application, and what information is needed for an additional active ingredient to be "specifically identifiable" based on the patent.
We are delighted to report that our client, Proteotype Diagnostics Ltd, has just been awarded a £1.5 million Cancer Mission Grant to advance the groundbreaking work they have been doing in early cancer detection with their innovative Enlighten™ test.
The role of artificial intelligence (AI) in the health sector is expanding, aiming to bring personalised healthcare to a broader audience. In the realm of femtech (the term used to define software and services that use technology tailored towards women’s health), AI’s significance is particularly pronounced.
Let’s delve deeper into the many applications relating to seaweed which are sculpting the patent landscape.
An Advocate General of the Court of Justice of the EU has handed down his non-binding opinion on the interpretation of EU law about supplementary protection certificates for combination medicinal products.
In the past few years, the number of FemTech companies and the interest in them has mushroomed. This growth is expected to continue as the public’s awareness of these issues continues to improve, alongside the increase in the amount of funding available for these companies.
The Metropolitan Court of Hungary (Fővárosi Törvényszék) has referred a new question to the Court of Justice of the EU (CJEU) about the requirements for obtaining supplementary protection certificates (SPCs). Joel Beevers explains what we know so far in this emergent case.